The largest database of trusted experimental protocols

S5136

Manufactured by Merck Group

The S5136 is a versatile laboratory equipment produced by Merck Group. It is designed to perform essential tasks in scientific research and analysis. The core function of this product is to provide reliable and accurate measurements or processing capabilities to support various laboratory applications.

Automatically generated - may contain errors

4 protocols using s5136

1

Evaluating TTR Aggregation Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of test compounds to prevent TTR aggregation was evaluated under the acidic conditions that favor TTR aggregation and fibril formation. A 2 μL solution of 167 μM human TTR (ACRO Biosystems #H5223) was incubated with 7 μL of 50 mM sodium acetate pH 4.0 (Sigma-Aldrich #S7545) and 100 mM KCl (Sigma-Aldrich #S5405) in the presence or absence of 1 μL TTR inhibitor for 72 h at 37 °C. At the end of the incubation, 3.5 μL of 500 mM sodium phosphate (Sigma-Aldrich #S5136) buffer pH = 8.0 was added to each sample for neutralization and 0.6 μL of 5% CHAPS (Sigma-Aldrich #C5070) as a detergent to prevent reassociation of protein. The cross-linking was performed by adding 1.5 μL of 5% glutaraldehyde solution (Sigma-Aldrich #G6257). After 4 min, the reaction was stopped by the addition of 2.5 μL freshly made 5% NaBH4. The samples were subjected to TTR Western blotting with prealbumin antibodies (1:500; Dako #A0002). Band intensity for TTR monomer and TTR aggregates was quantified from scanned images of the blots.
+ Open protocol
+ Expand
2

Evaluating TTR Aggregation Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ability of test compounds to prevent TTR aggregation was evaluated under the acidic conditions that favor TTR aggregation and fibril formation.63 (link),64 (link) A 2 μL solution of 167 μM human TTR (ACRO Biosystems #H5223) was incubated with 7 μL of 50 mM sodium acetate (pH = 4.0) (Sigma-Aldrich # S7545), and 100 mM KCl (Sigma-Aldrich # S5405) in the presence or absence of 1 μL of TTR inhibitor for 72 h at 37 °C. At the end of the incubation, 3.5 μL of a 500 mM sodium phosphate (Sigma-Aldrich #S5136) buffer (pH = 8.0) was added to each sample for neutralization and 0.6 μL of 5% CHAPS (Sigma-Aldrich #C5070) as a detergent to prevent reassociation of protein. The cross-linking was performed by adding 1.5 μL of 5% glutaraldehyde solution (Sigma-Aldrich # G6257). After 4 min, the reaction was stopped by the addition of 2.5 μL of freshly made 5% sodium borohydride (NaBH4). Samples were subjected to TTR Western blotting with prealbumin antibodies (1:500; Dako #A0002). Band intensity for TTR monomer and TTR aggregates was quantified from scanned images of the blots.
+ Open protocol
+ Expand
3

Hydrophobic Interaction Chromatography for Protein Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
HIC experiments were performed using a Waters Alliance 2695 system using Proteomix HIC Butyl-NP5 (4.6 × 50 mm, Sepax). The mobile phase was a gradient of 25 mM sodium phosphate pH 7 (S5136 and S5011, Sigma) with decreasing ammonium sulphate (2170, Merck) concentration (1.8 M to 0 M) and increasing concentration of isopropanol (AL03151000, Scharlab) to improve peaks resolution, as recommended by the column manufacturer, at a flow rate of 0.8 ml/min. The UV absorbance was measured at a wavelength of 214 nm.
+ Open protocol
+ Expand
4

Culture of Human Aortic VSMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human aorta VSMCs (354-05; Cell Applications Inc, San Diego, CA) were maintained in DMEM (D6171; Sigma) supplemented with 10% fetal bovine serum (F2442; Sigma), antibiotic-antimycotic solution (A5955; Sigma), and l-glutamine (G7513; Sigma). Cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were grown to confluence and used from passages 5 to 8. Experiments were performed on 2 cell lines derived from different donors. In some experiments, we cultured VSMCs in osteogenic medium that was obtained by supplementing the growth medium with inorganic phosphate (NaH 2 PO 4 -Na 2 HPO 4 , pH 7.4, 2.5 mmol/L; S5011 and S5136; Sigma) and CaCl 2 (0.6 mmol/L; C8106; Sigma).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!